IDNA vs. OZEM ETF Comparison

Comparison of iShares Genomics Immunology and Healthcare ETF (IDNA) to Roundhill GLP-1 & Weight Loss ETF (OZEM)
IDNA

iShares Genomics Immunology and Healthcare ETF

IDNA Description

The investment seeks to track the investment results of the NYSE FactSet Global Genomics and Immuno Biopharma Index. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Grade (RS Rating)

Last Trade

$22.86

Average Daily Volume

24,078

Number of Holdings *

38

* may have additional holdings in another (foreign) market
OZEM

Roundhill GLP-1 & Weight Loss ETF

OZEM Description OZEM targets the global weight management industry. The fund invests in companies involved in the development of GLP-1 and other weight loss drugs. GLP-1 agonists seek to aid in weight management by lowering blood sugar levels, reducing appetite, and promoting fullness. The portfolio consists of firms with GLP-1 and weight loss drugs that have been approved by or are currently undergoing Phase I, Phase II, and/or Phase III clinical trials of the US Food & Drug Administration (FDA), or any applicable food and drug regulator for non-US companies. The portfolio is constructed using a proprietary methodology, which selects companies with high levels of thematic relevance based on research of each companys public filings and disclosures. In addition, eligible securities must meet minimum market-cap and liquidity requirements. The actively managed fund, although rebalances portfolio weighting on at least a quarterly basis, may have a heavy concentration on a few names.

Grade (RS Rating)

Last Trade

$26.53

Average Daily Volume

75,803

Number of Holdings *

7

* may have additional holdings in another (foreign) market
Performance
Period IDNA OZEM
30 Days -4.65% 3.59%
60 Days -3.73%
90 Days -0.43%
12 Months -0.55%
0 Overlapping Holdings
Symbol Grade Weight in IDNA Weight in OZEM Overlap
IDNA Overweight 38 Positions Relative to OZEM
Symbol Grade Weight
SRPT C 5.39%
GILD C 4.46%
REGN B 4.41%
EXEL C 4.32%
INCY C 4.31%
RVMD D 4.05%
MRK C 3.99%
BGNE F 3.81%
BNTX F 3.37%
MRNA D 3.31%
TWST C 3.23%
SWTX D 2.92%
ACLX B 2.6%
GERN C 2.5%
BEAM D 2.12%
IOVA F 2.11%
NVAX C 1.98%
BPMC B 1.74%
LGND B 1.74%
DVAX F 1.72%
BCRX B 1.44%
NRIX C 1.39%
IBRX D 1.15%
CRSP F 1.15%
FDMT D 1.07%
VIR F 0.93%
RCUS F 0.86%
ABCL F 0.72%
ARCT F 0.7%
NTLA F 0.56%
DNA F 0.55%
EDIT F 0.45%
VALN F 0.43%
OABI F 0.42%
CVAC F 0.37%
XNCR F 0.3%
MGNX F 0.29%
QURE F 0.25%
IDNA Underweight 7 Positions Relative to OZEM
Symbol Grade Weight
LLY B -21.39%
NVO C -20.52%
AMGN B -4.2%
ALT F -3.97%
TERN C -3.32%
VKTX D -3.27%
GPCR F -3.14%
Compare ETFs